Previous 10 | Next 10 |
2024-02-16 14:41:23 ET Summary Health Catalyst, Inc. went public in 2019 but has experienced dropping revenue growth and worsening operating losses. The healthcare analytics market is expected to reach $164.6 billion by 2030, but Health Catalyst faces competition from larger playe...
SALT LAKE CITY, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2023 operating results on Thursday, February 22, 2...
Vitalware by Health Catalyst Earns Best in KLAS Achievement in Chargemaster Management PR Newswire SALT LAKE CITY , Feb. 7, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and ...
2024-01-26 10:08:35 ET Health Catalyst ( NASDAQ: HCAT ) was upgraded by analysts at Guggenheim, citing an improving macro-scenario that would boost technology demand and a better-than-expected operating leverage.... Read the full article on Seeking Alpha For further deta...
SacValley MedShare Selects Health Catalyst to Power its Qualified Health Information Organization (QHIO) PR Newswire SALT LAKE CITY , Jan. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics te...
2023-12-12 11:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation PR Newswire SALT LAKE CIT...
2023-11-22 15:23:00 ET More on Evolent Health, Health Catalyst, etc. Health Catalyst: After Q3 Earnings, I Continue To See This As A Buy Health Catalyst, Inc. (HCAT) Q3 2023 Earnings Call Transcript Omnicell, Inc. (OMCL) Q3 2023 Earnings Call Transcript Healt...
2023-11-14 08:26:12 ET Summary I reiterate a buy rating for HCAT stock due to its potential for growth acceleration and improved profitability. Management remains focused on profit improving initiatives. The stock has been derated, but if HCAT can improve margins, its valuatio...
2023-11-13 07:45:10 ET More on Health Catalyst Health Catalyst, Inc. (HCAT) Q3 2023 Earnings Call Transcript Health Catalyst Sees Growth In Tech-Enabled Managed Services Health Catalyst acquires cancer registry services provider Electronic Registry Systems He...
News, Short Squeeze, Breakout and More Instantly...
Health Catalyst Inc Company Name:
HCAT Stock Symbol:
NYSE Market:
2024-06-22 03:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive PR Newswire SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services t...
2024-05-21 18:30:04 ET Raymond James analyst issues UNDERPERFORM recommendation for HCAT on May 21, 2024 04:00PM ET. The previous analyst recommendation was Underperform. HCAT was trading at $6.77 at issue of the analyst recommendation. The overall analyst consensus : BU...